3 ms·
The President and other Republicans are currently making regulations requiring drug companies to charge US customers the same low rates they charge internationa
by drak0n1c 7y ago
The President and other Republicans are currently making regulations requiring drug companies to charge US customers the same low rates they charge international customers. The price difference is entirely in the price charged, this isn't a case of single payers offsetting the cost.
The US public has been subsidizing pharmaceutical research for the entire world with these inflated prices and hopefully that changes soon.
- rossenberg79 7y ago> The US public has been subsidizing pharmaceutical research for the entire world with these inflated prices and hopefully that changes soon. This is what some people refuse to acknowledge when they mock the US for having such high prices. If US prices drop over night to match RoW pharma companies are not just going to go quietly into that good night, there will be consequences. Most likely, a lowering of US prices will result in a rise everywhere else, so enjoy your low prices while they last. It’s time for Americans to put America first.
- mast 7y agoIs this really true? Is there any proof that companies don't or can't make a profit at European & Canadian prices. US prices are much higher because companies are allowed to charge more. https://www.healthaffairs.org/do/10.1377/hblog20170602.060376/full/ https://www.healthaffairs.org/do/10.1377/hblog20170602.06037...
- rossenberg79 7y agoResearch in pharma is expensive, you can easily spend billions and have nothing to show for it. Where else do you think all that money comes from?
- maxxxxx 7y agoIs anybody forcing them to sell in Europe? If it's not profitable I would assume they wouldn't sell there.
- maxxxxx 7y agoLet’s hope that something really comes out of this. From previous Republican healthcare attempts I have my doubts but maybe they will do the right thing this time.
- deleted 7y ago[deleted]
- consumer451 7y agoIf there was a true threat at their profit margins then I would think that a pharma index would reflect that. DRG does not. https://www.nasdaq.com/symbol/drg/stock-chart https://www.nasdaq.com/symbol/drg/stock-chart